Rare lephants

Prime Medicine, Inc.

PRME ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 27, 2026 FORM 4
4 Feb 24, 2026 FORM 4
4 Feb 24, 2026 FORM 4
SCHEDULE 13G/A Feb 17, 2026
8-K Jan 12, 2026 8-K
SCHEDULE 13G Nov 14, 2025
SCHEDULE 13G/A Nov 12, 2025
S-3ASR Nov 7, 2025 S-3ASR
10-Q Nov 7, 2025 10-Q
8-K Nov 7, 2025 8-K
SCHEDULE 13G/A Nov 5, 2025
8-K Sep 8, 2025 8-K
SCHEDULE 13D/A Aug 11, 2025
10-Q Aug 7, 2025 10-Q
8-K Aug 7, 2025 8-K
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
4 Aug 5, 2025 FORM 4
← Newer Page 2 of 12 · 298 filings Older →
Peter Lynch

Big companies have small moves, small companies have big moves.